8/22/2012 6:58:36 AM
EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced today that Jack Talley has resigned as President and CEO of the Company and as a member of the Board of Directors effective August 20, 2012. Alan W. Dunton, MD, Non-Executive Chairman of the Board of EpiCept, commented, “Mr. Talley joined EpiCept as President and CEO in October 2001. He was instrumental in the approval of Ceplene in the EU and obtaining a partnership for its launch. We wish Jack the best in his future endeavors."
comments powered by